Introduction: Integration of APP into Urologic Oncology Practice

Abstract

Improvements in the management of all stages and types of cancer have occurred at a rapid pace. Perhaps, where this is most apparent is in the area of advanced disease states. The traditional approach in the development of cancer therapeutics was to identify an active compound that worked in one type of cancer and then perform Phase 2 trials in a variety of other malignancies to determine its effect. Today’s therapeutic development programs rely upon the identification of precise alterations in the structure and/or function of the malignant cell and specifically targets those abnormalities. This concept is broadly known as precision medicine where the delivery of the intervention is targeted to the right patient at the right time.